Column Group IV GP, LP - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Column Group IV GP, LP is an investment firm tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $38.12M. Historical track record: 4/5 stars across 3 tracked purchases.
Profile
Column Group IV GP, LP is an investment firm that reports beneficial ownership of shares in Eikon Therapeutics, Inc. (EIKN) under U.S. securities law. It has submitted 1 SEC insider filing since 2026, most recently in February 2026.
| Filer type | Fund |
|---|---|
| Role | Insider |
| Notability | 20/100 |
Board memberships
- Eikon Therapeutics, Inc.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 0% |
| Avg 5-day return | -0.07% |
| Avg 30-day return | +2.83% |
| Avg 90-day return | -36.76% |
| Best 30-day return | +2.83% |
Trading Pattern
InsiderAlpha's records for Column Group IV GP, LP go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. The typical open-market purchase is $12.71M (3 buys totaling $38.12M). The largest single buy on record is $25.87M of EIKN in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Column Group IV GP, LP has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at Eikon Therapeutics, Inc. (EIKN) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | P - Open-market purchase | 630.9K | $18.00 | $11.36M |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | P - Open-market purchase | 49.6K | $18.00 | $892K |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | P - Open-market purchase | 1.44M | $18.00 | $25.87M |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 688.3K | - | |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 3.8K | - | |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 47.9K | - | |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 44.2K | - | |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 110.9K | - | |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 1.40M | - | |
| 2026-02-10 | EIKN | Eikon Therapeutics, Inc. | J - Other acquisition / disposition | 1.30M | - |
Most Active Insiders Right Now
Column Group IV GP, LP has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Connect Midstream, LLC
- CONSTELLATION SOFTWARE INC
- Lisa A. Conte
- Control Empresarial de Capitales S.A. de C.V.
- Leon G. Cooperman
- Corbin Capital Partners, L.P.
- Kenneth S. Courtis
- Cynosure Group, LLC
Frequently Asked Questions
What is Column Group IV GP, LP?
Column Group IV GP, LP is an investment firm that reports beneficial ownership of shares in Eikon Therapeutics, Inc. (EIKN) under U.S. securities law. It has submitted 1 SEC insider filing since 2026, most recently in February 2026.…
Has Column Group IV GP, LP been buying or selling stock?
Recorded transactions: 3 open-market purchases ($38.12M) and 0 open-market sales across all tracked filings.
How accurate is Column Group IV GP, LP's historical track record?
Across 3 tracked purchases, Column Group IV GP, LP averaged +2.8% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Column Group IV GP, LP's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Column Group IV GP, LP profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.